Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $18.30, but opened at $18.96. Enliven Therapeutics shares last traded at $18.77, with a volume of 11,556 shares changing hands. Wall Street Analyst Weigh In Separately, Mizuho started coverage on Enliven Therapeutics in […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s stock price rose 5.3% on Monday . The stock traded as high as $18.52 and last traded at $18.52. Approximately 101,232 shares were traded during trading, a decline of 27% from the average daily volume of 138,219 shares. The stock had previously closed at $17.59. Enliven Therapeutics […]
Commodore Capital LP boosted its position in shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) by 35.6% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 2,348,272 shares of the company’s stock after acquiring an additional 616,907 shares during the quarter. Enliven Therapeutics comprises […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $14.05, but opened at $13.59. Enliven Therapeutics shares last traded at $13.52, with a volume of 2,402 shares traded. Enliven Therapeutics Stock Up 0.6 % The firm’s 50-day moving average is […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) major shareholder 5Am Partners Vi, Llc sold 197,500 shares of Enliven Therapeutics stock in a transaction dated Tuesday, September 26th. The stock was sold at an average price of $15.00, for a total value of $2,962,500.00. Following the completion of the sale, the insider now directly owns […]